Diamorphine
- Generic Name
- Diamorphine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23NO5
- CAS Number
- 561-27-3
- Unique Ingredient Identifier
- 70D95007SX
- Background
Diamorphine (heroin) is a narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of t...
- Indication
Diamorphine, as a prescription medication in the United Kingdom, is indicated for use in the treatment of severe pain associated with surgical procedures, myocardial infarction or pain in the terminally ill and for the relief of dyspnoea in acute pulmonary edema .
- Associated Conditions
- -
- Associated Therapies
- -
Clinical Trials of Multivalent Opioid Vaccine Components
- Conditions
- Interventions
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 45
- Registration Number
- NCT04458545
- Locations
- 🇺🇸
Clinilabs Drug Development Corporation, Eatontown, New Jersey, United States
🇺🇸New York State Psychiatric Institute: Division on Substance Use Disorders, New York, New York, United States
Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV
- First Posted Date
- 2019-06-05
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- MetroHealth Medical Center
- Target Recruit Count
- 190
- Registration Number
- NCT03976258
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸Metrohealth Medical center, Cleveland, Ohio, United States
Pain Relief After Colorectal Surgery: Spinal Combined With Painbuster® vs Painbuster® Alone.
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2016-09-14
- Lead Sponsor
- York Teaching Hospitals NHS Foundation Trust
- Target Recruit Count
- 79
- Registration Number
- NCT02210260
- Locations
- 🇬🇧
Scarborough General Hospital, Scarborough, North Yorkshire, United Kingdom
Diamorphine or Alfentanil for Subcutaneous Use in Hospice In-patients?
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Gloucestershire Hospitals NHS Foundation Trust
- Target Recruit Count
- 18
- Registration Number
- NCT01049672
- Locations
- 🇬🇧
Sue Ryder Care Leckhampton Court Hospice, Cheltenham, Gloucestershire, United Kingdom
Abuse Liability of Suboxone Versus Subutex
- Conditions
- Interventions
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 19
- Registration Number
- NCT00710385
- Locations
- 🇺🇸
New York State Psychiatric Institute/Columbia University, New York, New York, United States
The German Project of Heroin Assisted Treatment of Opiate Dependent Patients
- Conditions
- Interventions
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 1015
- Registration Number
- NCT00268814
- Locations
- 🇩🇪
Studienambulanz, Frankfurt, Hessen, Germany
🇩🇪AWO Ambulanz, Karlsruhe, Baden-Wuertenberg, Germany
🇩🇪Heroinambulanz Koeln, Cologne, Northrhine-Westfalia, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.